Support: 888-992-3836
Copyright © 2023 InvestorsHub Inc.
Replies to post #79867 on Biotech Values
DewDiligence
11/02/11 7:22 AM
#130028 RE: DewDiligence #79867
XIENCE PRIME, which uses the same drug and biocompatible polymer as the XIENCE V Everolimus Eluting Coronary Stent System, features an enhanced stent design and a delivery system designed for greater flexibility, ideal radial strength, excellent longitudinal strength and more accurate stent placement.